Company Overview and News
DowDuPont Inc.’s (DWDP - Free Report) subsidiary — The Dow Chemical Company — recently declared plans to invest in an alkoxylation facility on the U.S. Gulf Coast. The move is likely to support global growth in its core end-markets including personal care, infrastructure and home. Additionally, the facility will also support the company’s end-markets where it is strengthening position for its brands such as Triton, Ecosurf, Tergitol, Carbowax and Sentry.
WLK FTI.WI MS.PRE FMC MS.PRF MS.PRG MS.PRA DWDP MS.PRI MS.PRK DOW MS CC
Shares of Cleveland-Cliffs Inc. (CLF - Free Report) have rallied around 25% quarter to date. The company has also outperformed its industry’s growth of roughly 5% over the same time frame. Cleveland-Cliffs, a Zacks Rank #1 (Strong Buy) stock, has a market cap of roughly $2.6 billion. Average volume of shares traded in the last three months was around 9,692.9K. Let’s take a look into the factors that are driving this mining company.
WLK FTI.WI FMC CC
Shares of Celanese Corporation (CE - Free Report) have popped around 14% over the past three months. The company has also outperformed its industry’s growth of a paltry 0.9% to over the same time frame. Celanese, a Zacks Rank #2 (Buy) stock, has a market cap of roughly $15.2 billion. Average volume of shares traded in the last three months is around 974.7k. The company has expected long-term earnings per share growth rate of 8.
WLK FTI.WI FMC CC CE
The Scotts Miracle-Gro Company (SMG - Free Report) recently said that consumer purchases of its lawn and garden products in May were at a record high of $565 million, leading to the near-full recovery of the decline reported by the company during the first seven months of the fiscal year. For the U.S. Consumer division, consumer purchases were nearly flat from 2017 levels on a year-to-date basis through Jun 10 with lawn fertilizer, growing media, grass seed and mulch witnessing positive growth.
WLK FTI.WI FMC CC SMG
Shares of The Mosaic Company (MOS - Free Report) have shot up around 20% quarter to date. The company has also outperformed its industry’s growth of roughly 18% over the same time frame. Mosaic, a Zacks Rank #3 (Hold) stock, has a market cap of roughly $11.3 billion. Average volume of shares traded in the last three months was around 4,211.9K. Mosaic has an expected long-term earnings per share growth rate of 7%.
MOS WLK FTI.WI FMC MOS.PRM CC
The chemical industry continues its positive run this year, sustaining the momentum witnessed in 2017. The industry’s upswing is backed by a resurgent global economy, strength across major end-markets, such as construction and automotive, and a recovery in demand for chemicals in the energy market supported by a rebound in oil prices. Notwithstanding some headwinds, the industry’s upturn is expected to continue in the short haul as the fundamental driving factors remain firmly in place.
FTI.WI FMC CC IOSP MEOH
Steel Dynamics, Inc.'s (STLD - Free Report) stock looks promising at the moment. The company has seen its shares pop around 10% over the last six months. We are positive on the company’s prospects and believe that the time is right for you to add the stock to portfolio as it looks promising and is poised to carry the momentum ahead. Let’s delve deeper into the factors that make this steel maker an attractive investment option.
NEE.PRI NEE.PRJ STLD WLK NEE.PRC FTI.WI FMC NEE.PRQ NEE.PRR CC NEE
DowDuPont Inc.’s (DWDP - Free Report) subsidiary — The Dow Chemical Company — has declared a series of phased, incremental investments for expanding its global glycol ethers facility. The move will help the company to address the increasing demand in major end-markets and applications. Once completed, the company’s existing capacity of these product lines is expected to nearly double. Notably, the company intends to boost production capacity of select p-series and performance glycol ethers product lines, which includes Dowanol Glycol Ethers, through a series of seven de-bottlenecking and incremental expansion projects.
WLK FTI.WI FMC DWDP NEE.PRI NEE.PRJ NEE.PRC DOW NEE.PRQ NEE.PRR CC NEE
LAKE FOREST, Ill., June 19, 2018 (GLOBE NEWSWIRE) -- Stericycle, Inc. (Nasdaq:SRCL) today announced the appointment of Veronica M. “Ronee” Hagen and Kay G. Priestly to the Stericycle Board of Directors and the departure of John Patience from the Board.
SOJA SPPJY SO TRQ NGD RIO RIO NEM FTI.WI NGDAF FTI NGD ETR RTPPF RIO SGY RTNTF TRQ
Cabot Corporation (CBT - Free Report) and Nexeo Solutions have expanded their agreement to distribute the former’s specialty carbon, fumed alumina, fumed silica, aerogel and dispersion product lines in Canada. Cabot stated that working with Nexeo Solutions for distributing its high-value products has proved to be beneficial for customers. The company is pleased to expand the partnership and believes that working with Nexeo Solutions will help to deliver meaningful benefits to its customers in Canada.
NXEOW WLK CBT FTI.WI FMC NXEO NXEOU CE
Kinross Gold Corporation (KGC - Free Report) said that it is proceeding with the initial Gilmore expansion project at its Fort Knox mine, Alaska. The company expects the project to extend Fort Knox’s mining by six years to 2027 and leaching to 2030 and also increase mine life production by roughly 1.5 million gold equivalent ounces. Notably, the project involves a low initial capital cost of roughly $100 million.
SPG.PRJ KGC WLK FTI.WI FMC K SPG CE
In a widely expected move, the Federal Reserve raised its benchmark rate for the second time this year on Wednesday. The central bank also increased the number of projected rate hikes for this year from three to four. Further, the Fed offered a more favorable opinion on growth and inflation, raising its forecasts for the year.
CIVB BPOP FTI.WI FMC ASB-D ASB-C CIVBP FFNW BPOPP BPOPO ASB.WS MNSB BPOPM BPOPN ASB.PRD ASB ASB.PRC
We are positive on Ingevity Corporation’s (NGVT - Free Report) prospects and believe that the time is right for you to buy the stock as it looks promising and is poised to continue the momentum. Let’s delve deeper into the factors that make this Zacks Rank #2 (Buy) stock an attractive investment option. What Makes NGVT an Attractive Pick An Outperformer: Ingevity has outperformed the industry it belongs to over the past six months.
WLK FTI.WI FMC NGVT NGVT.WI CE
Air Products and Chemicals Inc. (APD - Free Report) will showcase a new gas density sensor at Powdermet 2018, the International Conference on Powder Metallurgy & Particulate Materials, to be held from June 17-20 in San Antonio, TX. The sensor comes with the ability to measure the hydrogen concentration in sintering furnaces that utilize a nitrogen-hydrogen blend as the hot zone atmosphere. It is important for the furnace to be continuously measured and controlled.
XOM FTI.WI FMC CC CE
ArcelorMittal (MT - Free Report) has started constructing new premises at its site in Ghent, Belgium to build a new installation that will convert carbon-containing gas into bioethanol from its blast furnaces. In line with this, it has inked a long-term partnership deal with the Chicago-based LanzaTech, which pioneered the gas conversion process technology. LanzaTech’s licensed technology employs microbes that feed on carbon monoxide to produce bioethanol, which will then be used as transport fuel and potentially in plastics production.
MT WLK XOM FTI.WI FMC MT CE
7h - Asif
Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...
8h - Asif
Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...
2018-06-18 - Asif
Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...
as of ET